Panagora Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-199,945
| Closed | -$1.16M | – | 1582 |
|
|
2022
Q1 | $1.16M | Sell |
199,945
-401,576
| -67% | -$2.33M | 0.01% | 869 |
|
|
2021
Q4 | $4.51M | Sell |
601,521
-9,069
| -1% | -$68K | 0.02% | 429 |
|
|
2021
Q3 | $5.5M | Buy |
610,590
+4,693
| +0.8% | +$42.3K | 0.03% | 405 |
|
|
2021
Q2 | $7.25M | Sell |
605,897
-29,671
| -5% | -$355K | 0.04% | 365 |
|
|
2021
Q1 | $7.96M | Sell |
635,568
-16,963
| -3% | -$213K | 0.04% | 358 |
|
|
2020
Q4 | $10.2M | Buy |
652,531
+167,489
| +35% | +$2.61M | 0.06% | 276 |
|
|
2020
Q3 | $4.58M | Buy |
485,042
+17,955
| +4% | +$170K | 0.03% | 414 |
|
|
2020
Q2 | $4.19M | Buy |
467,087
+104,326
| +29% | +$935K | 0.03% | 449 |
|
|
2020
Q1 | $2.31M | Buy |
362,761
+194,758
| +116% | +$1.24M | 0.02% | 551 |
|
|
2019
Q4 | $1.41M | Buy |
+168,003
| New | +$1.41M | 0.01% | 920 |
|
|
2017
Q3 | – | Sell |
-2,693
| Closed | -$24K | – | 2473 |
|
|
2017
Q2 | $24K | Buy |
+2,693
| New | +$24K | ﹤0.01% | 2223 |
|
|
2016
Q2 | – | Sell |
-4,469
| Closed | -$27K | – | 2344 |
|
|
2016
Q1 | $27K | Hold |
4,469
| – | – | ﹤0.01% | 2102 |
|
|
2015
Q4 | $41K | Buy |
4,469
+497
| +13% | +$4.56K | ﹤0.01% | 2028 |
|
|
2015
Q3 | $22K | Buy |
+3,972
| New | +$22K | ﹤0.01% | 2129 |
|
|
2015
Q2 | – | Sell |
-12,828
| Closed | -$201K | – | 2466 |
|
|
2015
Q1 | $201K | Buy |
+12,828
| New | +$201K | ﹤0.01% | 1666 |
|